An introduction to Talisman Therapeutics by Dr. Martin Crossley, alongside some context on why this work is so important – the current and projected trends in global dementia research and care:

Dr. Tom Campbell introduces Talisman’s proprietary neuron-microglia co-cultures, and presents recent data characterising the network dynamics and neuroinflammatory phenotypes of these complex, fully human systems:


ADPD 2023 Posters

Microglia regulate levels of extracellular, neuron-derived tau in an activation-dependent manner







MTBR/C-terminal tau fragments are abundant in tauopathy brain and efficiently endocytosed by human neurons







Binding of Soluble Amyloid Beta Oligomer Species to Human iPSC-Derived Excitatory Neurons Assessed Using a Panel of Amyloid Beta Antibodies